This approach demonstrates a remarkable reduction in the relative gene expression levels of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and Bcl-2, accompanied by the induction of apoptosis and the inhibition of migration in BC cells [74]. The gene discussed is NFKB1; the disease is breast cancer.